A comparative trial of timolol and flutonidin as antihypertensive agents

A. Salvadeo, S. Segagni, G. Villa, F. Galli, W. Piazza, G. Bovio

Research output: Contribution to journalArticlepeer-review

Abstract

In a double-blind cross-over clinical trial, flutonidin (2-4 mg daily) was compared with timolol (20-40 mg daily) in the treatment of mildly or moderately hypertensive patients who concomitantly received fixed diuretic treatment. Each drug was administered for 1 month, with an interval of 2 weeks between the two monthly periods. During administration of flutonidin, blood pressure initially fell but returned to baseline values at the end of treatment. Heart rate was not affected by the drug. Timolol significantly reduced both blood pressure and heart rate. Its effect becomes evident during the 1st week and increases throughout the treatment period. Side effects were more frequent during flutonidin administration than during timolol administration. No significant modifications of the laboratory findings were observed during either flutonidin or timolol treatment.

Original languageEnglish
Pages (from-to)78-84
Number of pages7
JournalInternational Journal of Clinical Pharmacology Therapy and Toxicology
Volume20
Issue number2
Publication statusPublished - 1982

ASJC Scopus subject areas

  • Toxicology
  • Pharmacology (medical)

Fingerprint Dive into the research topics of 'A comparative trial of timolol and flutonidin as antihypertensive agents'. Together they form a unique fingerprint.

Cite this